Gritstone Oncology CEO on leveraging cancer drug development for coronavirus vaccine

Gritstone Oncology CEO Andrew Allen explained how the nascent cancer drug developer caught the attention of the Gates Foundation in developing a potential coronavirus vaccine to slow the emergence of Covid-19 variants.
Wed, Jan 20 20217:42 PM EST